SCHEMBL13136706

SCHEMBL13136706

CNCCc1ccccc1CC(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.52
TAAR1 Q96RJ0 4/20 0.52
ATM Q13315 1/20 0.48
TDP1 Q9NUW8 1/20 0.46
PTGS2 P35354 3/20 0.45
BCAT2 O15382 1/20 0.45
CXCL8 P10145 3/20 0.44
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42
AKR1B10 O60218 1/20 0.41
UGT1A9 O60656 1/20 0.41
TRPA1 O75762 1/20 0.41
ABCB11 O95342 1/20 0.41
MT-CO2 P00403 1/20 0.41
TTR P02766 1/20 0.41
ALB P02768 1/20 0.41
UGT1A6 P19224 1/20 0.41
UGT1A1 P22309 1/20 0.41
PTGS1 P23219 1/20 0.41
CXCR1 P25024 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11468455 0.81 AKR1B1 (0.55) AKR1B1TDP1PTGS2BCAT2CXCL8
Methyl Alcohol SCHEMBL28299530 0.80 AKR1B1 (0.70) AKR1B1TDP1PTGS2BCAT2CXCL8
SCHEMBL30359 0.79 AKR1B1 (0.76) AKR1B1TDP1PTGS2BCAT2CXCL8
SCHEMBL29410826 0.79 AKR1B1 (0.76) AKR1B1TDP1PTGS2BCAT2CXCL8
Hydrochloric Acid SCHEMBL11484601 0.79 AKR1B1 (0.53) AKR1B1TDP1PTGS2BCAT2CXCL8
SCHEMBL4032382 0.79 AKR1B1 (0.57) AKR1B1TDP1PTGS2BCAT2CXCL8
SCHEMBL3053777 0.78 TAAR1 (0.61) TAAR1ATMTDP1MTNR1AMTNR1B
SCHEMBL11526125 0.78 FOLH1 (0.59) TAAR1ATMALDH1A1HTT
SCHEMBL28842838 0.77 AKR1B1 (0.73) AKR1B1TDP1PTGS2BCAT2CXCL8
Hydrochloric Acid SCHEMBL6767821 0.77 AKR1B1 (0.73) AKR1B1TDP1PTGS2BCAT2CXCL8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100222326-A1 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders UCB PHARMA, S.A. (BE) 2010-09-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100222326-A1 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders CNR2, CNR1, SLC18A2 AKR1B1 1913/4885TAAR1 160/4885ATM 4178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.